Ekman Lars
SEC-identified person · CIK 1376117 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Prothena Corp plc PRTA | Director | filed 2012 - 2026 |
| Amarin Corp PLC\UK AMRN | Director | filed 2010 - 2022 |
| Ultragenyx Pharmaceutical Inc. RARE | Director | filed 2016 - 2022 |
| Spark Therapeutics, Inc. ONCE | Director | filed 2015 - 2019 |
| Sophiris BIO INC. SPHS | Director | filed 2013 - 2019 |
| Intermune INC ITMN | Director | filed 2006 - 2014 |
| Tranzyme INC TZYM | Director | filed 2013 - 2014 |
| Aryx Therapeutics, Inc. ARYX | Director | filed 2007 - 2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.